Related Experiment Videos
Therapeutic controversy: The safety of third-generation oral contraceptives
R L Barbieri1, L Speroff, A M Walker
1Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. rlbarbieri@bics.bwh.Harvard.edu
The Journal of Clinical Endocrinology and Metabolism
|June 18, 1999
Abstract
No abstract available in PubMed .
Keywords:
AmericasBiologyContraceptionContraceptive AgentsContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive MethodsDeveloped CountriesDiseasesEmbolismFamily PlanningHealthNorth AmericaNorthern AmericaOral ContraceptivesPublic HealthRisk FactorsSafetyThromboembolismUnited StatesVascular Diseases